SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-24-000160
Filing Date
2024-02-14
Accepted
2024-02-14 16:03:00
Documents
80
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q igcpharma20231231_10q.htm   iXBRL 10-Q 1150624
2 EXHIBIT 31.1 ex_625338.htm EX-31.1 14682
3 EXHIBIT 31.2 ex_625339.htm EX-31.2 14780
4 EXHIBIT 32.1 ex_625340.htm EX-32.1 7866
10 igcpharma_001.jpg GRAPHIC 1863
11 igcpharma_002.jpg GRAPHIC 1285
  Complete submission text file 0001185185-24-000160.txt   5916351

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA igc-20231231.xsd EX-101.SCH 49079
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE igc-20231231_cal.xml EX-101.CAL 41603
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igc-20231231_def.xml EX-101.DEF 215527
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20231231_lab.xml EX-101.LAB 409976
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20231231_pre.xml EX-101.PRE 230927
81 EXTRACTED XBRL INSTANCE DOCUMENT igcpharma20231231_10q_htm.xml XML 1024025
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

IRS No.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-32830 | Film No.: 24637576
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)